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Abstract
Background: We evaluated the periodontal conditions in patients with type 2 diabetes mellitus compared to
metabolically healthy controls, and determined whether periodontal interleukin genotypes and microorganisms
differed between participants with and without type 2 diabetes mellitus.
Methods: From April 2011 to July 2012, we prospectively enrolled healthy controls and patients with type 2
diabetes mellitus. Evaluation included assessment of medical and periodontal findings. We also recorded the
presence of several interleukin gene variants and specific microorganisms, both available through commercially
available diagnostic kits. Statistical significance was tested by the chi-square test and student’s t-test.
Results: We enrolled 52 patients with type 2 diabetes mellitus and 52 healthy controls. Compared with controls,
periodontal disease was significantly more severe in patients with type 2 diabetes mellitus for the following: plaque
index, bleeding on probing, pocket probing depth, clinical attachment loss, severe periodontal destruction (i.e., clinical
attachment loss≥ 5 mm), and number of teeth. However, statistical analysis failed to detect significant differences with
respect to the periodontal-related interleukin genotypes (p≥ 0.58) or the selected oral microbiota (p≥ 0.15).
Conclusion: Based on these results, it may be assumed that chronic periodontitis in patients with type 2 diabetes
mellitus is most strongly associated with inadequate oral hygiene. Periodontal interleukin genotypes and differences
in oral microbiota seem to play a subordinate role.
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Background
Periodontitis is a common chronic disease of tooth-
supporting tissues caused by bacterial deposits that ac-
cumulate on the tooth surface and form dental plaque
[1]. Over recent years, there has been increased interest
in determining whether a link exists between periodon-
tal health and overall health or disease [1–4]. As a local
oral inflammatory disease, periodontitis may induce
and perpetuate systemic inflammation that aggravates
cardiovascular disease, pulmonary disease, rheumatoid
arthritis, and diabetes mellitus (DM) [1].
The most common human endocrine disease, DM is a
metabolic disorder characterized by chronic hypergly-
cemia [5]. Type 2 DM (T2DM) is the most prevalent type,
occurring in 90 %–95 % of all patients with DM [6, 7].
Poor glycemic control in patients with T2DM leads to
prolonged blood glucose elevations that damages blood
vessels and causes a plethora of associated complications.
These include atherosclerosis, myocardial infarction, ret-
inopathy, nephropathy, neuropathy, delayed wound heal-
ing, and an increased risk of infection [8].
Several studies have investigated the association between
periodontal disease and DM [9], generally concluding that
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patients with T2DM had more extensive periodontal
disease than nondiabetic controls [10]. Although oral
hygiene seems to be key to the progression of severe
periodontal destruction [11], it is equally plausible that
other intrinsic factors are influential. Accordingly, re-
cent literature has produced conflicting data as to whether
patients with DM and comorbid chronic periodontitis
have an altered subgingival microbiota compared with
healthy controls [12]. In addition, the influence of a gen-
etic polymorphism in the interleukin 1 gene cluster, espe-
cially the interleukin 1 beta (IL1B) (+3954) genotype,
remains a matter of debate [11, 13].
From a therapeutic perspective, it would be interesting
to know which variables contribute most significantly to
periodontitis in T2DM. It would be equally useful to
know whether these patients are affected by periodontal-
related interleukin genotype polymorphisms and destruc-
tive oral microbiota significantly more often than healthy
controls. Detection of such genetic and microbial differ-
ences might have a major impact on periodontal treat-
ment in patients with T2DM.
The primary aim of this study was to evaluate the
differences in periodontal conditions and influencing
variables, such as oral hygiene, between patients with
T2DM and healthy controls. In addition, we aimed to
evaluate whether there were significant differences in
the presence of polymorphisms in the periodontal
interleukin 1 genotype and oral microbiota between pa-
tients with T2DM and healthy controls.
Methods
Study design
This prospective clinical study took place from April 2011
to July 2012 in the outpatient department for internal
medicine at the Technical University of Munich. Patients
with T2DM diagnosed for at least one year, aged at least
18 years, and attending the internal medicine outpatient
department of our university hospital were approached
and informed of the study’s aims. For comparison, a con-
trol group was recruited from among metabolically
healthy patients attending the same department. The
study was performed in accordance with the ethical stan-
dards of the Declaration of Helsinki and approved by the
institutional ethics board of the Technische Universität
München, Klinikum rechts der Isar.
Participants
We included dentate patients who had at least eight
remaining teeth (i.e., two molars, two premolars, and
four anterior teeth per jaw, free of prosthetic crown res-
toration) [8]. Patients were excluded if they had fewer
teeth, had used antibiotics in the past three months, or
were treated circumferentially with prosthetic bridge or
crown restorations [8]. Additionally, were also excluded
patients with removable dental restorations and those
who had attended periodontal therapy or dental prophy-
laxis appointments within the last six months [8]. With
respect to general health, patients were excluded if they
had undergone head and neck radiotherapy, systemic
bisphosphonate therapy, or were suffering from heart
defects or immunosuppression (e.g., corticoid therapy or
HIV infection). Finally, pregnant or lactating women
were also excluded. To eliminate bias, a single dentist
(JK), who was blinded to whether a patient had diabetes,
performed all the dental exams.
Sample size calculation
The sample size was calculated by reference to pocket
probing depth (PPD) and clinical attachment loss (CAL)
in patients with and without periodontitis [14, 15] in the
control and T2DM groups. With respect to PPD, a sam-
ple size of 44 per group was needed to give a 90 %
power to detect a mean difference of 0.5 mm (ratio of
standard deviation: 0.8) using a two group Satterthwaite
t-test with a 0.05 two-sided significance level. With re-
spect to CAL, a sample size of 48 per group was needed
to give a power of 80 % to detect a mean difference of
0.9 mm (ratio of standard deviation: 0.9).
Variables
Medical evaluation
All medical information could be extracted from the
patient’s medical charts. Using standardized forms, age,
gender, body mass index (BMI) [16], and smoking sta-
tus (yes/no) were recorded from these charts. Metabolic
control was determined by recording the fasting glu-
cose and the glycated hemoglobin (HbA1c) levels from
the charts of participants. Finally, we recorded what
therapies and medications the patients and controls
were receiving.
Periodontal evaluation
Periodontal evaluation took place under standardized
conditions with the same examiner (JK). Oral hygiene
was measured for each tooth according to the plaque
index (PI) [17], as follows. A score of 0 was given for no
plaque. A score of 1 for a film of plaque that was adher-
ent to the free gingival margin and adjacent area of the
tooth. Moderate accumulation of soft deposits within
the gingival pocket, or of the tooth and gingival margin,
but that were macroscopically visible, were assigned a
score of 2. Abundant soft matter within the gingival
pocket and/or on the tooth and gingival margin was
assigned a score of 3. For assessment of bleeding sites
indicative of local inflammation, a modified bleeding-on-
probing (BOP) index was scored as a percentage of sites
that showed bleeding 30 s after gentle probing of the
bottom of the pockets [18, 19].
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The PPD was measured to the nearest millimeter on
all teeth, except the third molars, and on four sites
(mesio-vestibular, disto-vestibular, mesio-oral and disto-
oral) from the gingival margin to the base of the pocket
or crevice with a WHO probe (Morita, Kyoto/Japan)
[20]. In each of these sites, the CAL was also measured
from the cemento-enamel junction to the bottom of the
pocket [5]. For each individual, the periodontal condition
was characterized by its severity and extent. Severity was
described for all the individual sites as a whole and was
categorized as severe in case of a CAL ≥ 5 mm [11, 21].
Extent was characterized as localized if ≤30 % of the sites
were affected and generalized if >30 % of the sites were
affected withCAL ≥ 1 mm [21].
In addition, the total number of teeth was recorded.
Finally, tooth mobility was assessed manually and classi-
fied into four grades: 0, normal, no mobility; 1, minimal
mobility; 2, visible mobility (≤1 mm); and 3, marked in-
stability (>1 mm) [22].
The examiner demonstrated reproducibility of peri-
odontal parameter measurements. Prior to the study,
both the clinical examiner (JK) and an experienced
clinician (HD) assessed the PI, BOP index, PPD, CAL,
and tooth mobility in a sample of 10 subjects. Cohen’s
kappa coefficients were calculated for each parameter,
and ranged between 0.71 and 0.92, which showed good
inter-rater reliability. Three days later, intra-rater reliability
was confirmed in the same 10 subjects, producing kappa
values between 0.81 and 0.89.
Genetic diagnosis
We used the commercially available diagnostic test,
Geno Type®IL-1 (Hain Lifescience, D–Nehren). This
produces four different genetic patterns by DNA
hybridization to allow evaluation of hereditary propen-
sity to infection, which we labeled groups A to D based
on positivity for interleukin 1 alpha (IL1A), IL1B, and
interleukin 1 receptor antagonist (IL1RN) genotypes. In
group A, the genotype was not positive for either IL1A,
IL1B, or IL1RN. In group B, the genotype was negative
for IL1A and IL1B, but positive for IL1RN. In group C,
the IL1A and IL1B genotypes were positive, but IL1RN
was negative. Finally, in group D, the genotype was posi-
tive for IL1A, IL1B, and IL1RN. Clinically, groups C and
D were expected to be more likely to develop periodon-
titis than were groups A and B. Sampling of oral muco-
sal cells was performed using a sterile swab that was
placed into a container and sent to the Hain Lifescience
Company for analysis.
Microbiology
It was demonstrated by Socransky et al. in 1998 that bac-
terial species exist in complexes in subgingival plaque,
most probably due to synergistic effects [23, 24]. Five
major clusters were consistently observed, the so-called
red, orange, green, yellow, and purple clusters. The
commercially available Micro-IDent®plus Test (Hain
Lifescience, D–Nehren) allows detection of eleven peri-
odontal pathogenic bacteria using polymerase chain
reaction. Accordingly, the test uses a small and limited
spectrum of selected microorganisms. It describes eight
profiles of complexes with respect to possible antibiotic
therapies. Profile 1 detects microbiota of the Aa-com-
plex; Profile 2, of the red and orange complex; and
Profile 3, of the red and orange complexes plus Peptos-
treptococcus micros. In turn, Profile 4 detects bacteria
of the orange complex; Profile 5, of the green complex;
and Profile 6, a combination of the Aa- and green com-
plexes. Profile 7, similar to Profile 8, detects a combin-
ation of the Aa-complex, green complex, and the red
and orange complexes, with the difference being that
the concentration of Peptostreptococcus micros in Pro-
file 7 does not require therapy.
In each patient, subgingival plaque samples were ob-
tained using sterile paper points, which were placed with
sterile forceps for 10 s in the deepest periodontal pocket
of each sextant of the jaw. Cotton rolls were used to iso-
late the sampling area from saliva. Paper points were
placed into a container and sent to the Hain Lifescience
Company for analysis.
Statistical analysis
The data were analyzed using IBM SPSS for Windows,
Version 19.0 (IBM Corp., Armonk, NY, USA), and a P-
value less than 0.05 was considered to indicate statistical
significance in all analyses. Data of the clinical parame-
ters are presented as means ± standard deviations, or as
continuous variables and proportions. The statistical sig-
nificance of difference in proportions was tested by the
chi-square test. Statistical testing between continuous
variables was performed using student’s t tests. Correla-
tions between medical and periodontal findings were an-
alyzed by statistical means, using BOP, CAL ≥ 5 mm, and
number of teeth [11].
Results
Patients
Among the patients invited to participate in this study,
250 fulfilled the inclusion criteria (178 patients with
T2DM and 72 controls). In accordance with the power
calculation, we obtained written informed consent for
dental evaluation from 52 patients with type 2 DM and
52 patients with healthy metabolisms. All participants
were white Caucasians. According to the chart reviews,
both groups were comparable with respect to all dis-
eases, except for the implantation of cardiac pacemakers
(p = 0.04) and presence of hepatitis B and C (p = 0.03),
which were significantly more common in the T2DM
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group (Fig. 1 and Table 1). Statistical analysis revealed
no significant difference between the groups in age, gen-
der, or smoking habits, but the T2DM group did have
significantly higher mean impaired fasting glucose values
compared with controls. Moreover, mean HbA1c and
BMI values were significantly higher in the T2DM group
compared with the control group. The mean duration of
diabetes was 8.9 ± 6.3 years.
Periodontal findings
Plaque index values indicated significantly better oral hy-
giene in the control group compared with the T2DM
group. According to the BOP index, the T2DM group
demonstrated significantly more bleeding sites than the
control group. Moreover, these patients showed signifi-
cantly higher mean PPD and CAL values, as well as sig-
nificantly more severely affected periodontal pockets
(CAL ≥ 5 mm), compared with controls. Similarly, more
patients in the T2DM group suffered from generalized
periodontitis and visible mobility or marked instability
of teeth (scores 3 and 4). In addition, the T2DM group
had significantly less teeth than the control group, but
there was no statistically significant difference between
the groups with respect to localized periodontitis or
tooth mobility (scores 1 and 2) (Table 2).
Tables 3 and 4 demonstrate that the estimated peri-
odontal parameters were related to age in the T2DM
group, but not in the control group. For patients with
T2DM who were older than 45 years, periodontal dis-
ease was more severe. With respect to good glycemic
control (HbA1c < 7), patients with T2DM had a signifi-
cantly lower mean BOP index than patients with poor
glycemic control (HbA1c ≥ 7). However, comparison of
HbA1c levels with severe periodontal destruction
(CAL ≥ 5 mm) and number of teeth did not reach statis-
tical significance in the T2DM group. Among the con-
trol group, no individuals had a HbA1c level ≥ 7;
accordingly, statistical analysis could not be performed.
With respect to smoking habits, there were no signifi-
cant differences in the three estimated parameters for
current smokers versus former and never smokers in the
T2DM group. Only severe periodontal destruction
(CAL ≥ 5 mm) differed significantly between current and
formerly/never smokers in the control group. Tables 3
and 4 also demonstrate that among the estimated peri-
odontal parameters, BOP and severe periodontal destruc-
tion (a CAL ≥ 5 mm), but not the number of teeth, were
significantly related to the patients’ oral hygiene levels
(PI ≥ 1) in both the T2DM and control groups.
Genetic and microbiologic findings
According to the four genetic groups, A to D, the chi-
square-test demonstrated no statistically significant differ-
ences between the T2DM and control groups (p ≥ 0.58).
Similarly, statistical analysis failed to detect significant dif-
ferences between the groups in terms of the selected oral
Met criteria: 250 patients






Fig. 1 Flowchart showing the distribution of patients included into
the study






Subjects (male/female; N) 36 / 16 27 / 25 0.07
Age (years; mean ± SD) 63.4 ± 13.6 58.8 ± 13.5 0.08
Current smoker (n, %) 9 (17.3 %) 6 (11.5 %) 0.40
Former and never smokers (n, %) 43 (82.7 %) 46 (88.5 %) 0.81
Fasting glucose (mg/dl, mean ± SD) 179.4 ± 80.3 100.8 ± 14.6 <0.001
HbA1c level (%, mean ± SD) 7.1 ± 1.7 5.4 ± 0.5 <0.001
BMI (kg/m2, mean ± SD) 28 ± 5.9 25.8 ± 4.8 0.039
Table 2 Periodontal findings and monitored parameters in the






PI (score 0–3) (mean ± SD) 1.6 ± 0.2 1.2 ± 0.1 <0.001
BOP (%) (mean ± SD) 7.0 ± 6.9 2.4 ± 2.8 <0.001
PPD (mm) (mean ± SD) 4.6 ± 0.9 4.0 ± 0.8 <0.001
CAL (mm) (mean ± SD) 7.4 ± 1.6 6.5 ± 1.5 0.003
Severe periodontitis
(CAL≥ 5 mm) n (%)
38 (73.1 %) 19 (36.5 %) <0.001
Generalized periodontitis n (%) 10 (19 %) 1 (2 %) 0.004
Localized periodontitis n (%) 38 (73 %) 36 (69 %) 0.66
Number of Teeth (mean ± SD) 16.8 ± 8.7 21 ± 8.5 0.014
Mobility Grade 0 and 1, n (%) 41 (78.8 % ) 49 (94.2 %) 0.34
Mobility Grade 2 and 3, n (%) 11 (2.11 %) 3 (5.8 %) 0.044
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microbiota (p ≥ 0.15) (Tables 4 and 5). Although concen-
trations of bacteria generally did not differ significantly
between both groups, those of F. nucleatum (p = 0.029)
and E. corrodens (p = 0.042) were higher in the control
group, while that of C. rectus was higher in the T2DM
group (p = 0.031).
Discussion
Periodontitis and DM both place enormous costs on the
public health care system [25, 26]. Therefore, clinical
studies that address both diseases are urgently needed.
Accordingly, we aimed to compare the periodontal con-
ditions between patients with T2DM and healthy con-
trols, with a specific interest in the roles of differences in
specific genetic polymorphisms and oral microbiota, be-
cause such differences might affect periodontal treat-
ment in patients with T2DM.
In this study, 72.2 % of controls (52 of 72) partici-
pated in the study, compared with 29.2 % of patients
with T2DM (52 of 178), which is consistent with the
known literature [11]. With respect to age, gender, and
smoking habits, there were no statistically significant
differences between patients and controls, which is
also consistent with the literature [4, 8, 18, 27]. How-
ever, the percentage of smokers was below the German
mean (27.6 %), which might be attributable to the rela-
tively small sample size [28].
Periodontal findings
We assessed periodontal status without x-rays because
of the poor ability of this imaging modality to reflect the
real periodontal situation [29, 30]. Indeed, our clinical
results showed that periodontal disease was significantly
worse in patients with T2DM on most parameters (PI,
BOP, PPD, CAL, CAL ≥ 5 mm, number of teeth, and
scores of 2 and 3 on tooth mobility) (Table 2). These
findings are consistent with the data of other studies [4,
31, 32]. Also similar to our results, patients with T2DM
in another clinical study had 18 ± 7 teeth, which com-
pared with 22 ± 5 teeth in their control group [33].
With respect to age, only patients with T2DM who
were older than 45 years showed significantly worse
periodontal disease, but this difference did not persist
when older and younger controls were compared (Ta-
bles 3 and 4). Accordingly, we concluded that age was
not a significant influencing factor in this study. Simi-
larly, previous studies of patients with DM have failed to
demonstrate a positive correlation between the peri-
odontal state and age, instead suggesting that age was
much less important when oral hygiene status was taken
into consideration [34].
The degree of glycemic control, as indicated by the
HbA1c level, is claimed to be an important variable in
the relationship between DM and periodontal diseases.
In another study, HbA1c values were shown to be sig-
nificantly associated with severe periodontal destruction
Table 3 Correlation of medical and periodontal findings in patients with T2DM
Variable BOP (%) Mean ± SD P-value CAL≥ 5 mm % (n) P-value Number of teeth Mean ± SD P-value
Age≥ 45 years 6.47 ± 7.1 (n = 43) 0.18 87.8 (n = 36/41) <0.001 15.65 ± 8.6 (n = 43) <0.001
Age < 45 years 3.25 ± 0.35 (n = 9) 18.2 (n = 2/11) 27.00 ± 1.41 (n = 9)
HbA1c≥ 7 % 10.81 ± 8.2 (n = 18) <0.001 83.3 (n = 15/18) 0.31 14.00 ± 8.8 (n = 18) 0.19
HbA1c < 7 % 3.65 ± 4.30 (n = 34) 70.58 (n = 24/34) 17.38 ± 8.72 (n = 34)
Current smokers 7.42 ± 6.56 (n = 9) 0.77 66.6 (n = 6/9) 0.17 14.33 ± 10.6 (n = 9) 0.52
Former and never smokers 6.67 ± 7.26 (n = 43) 74.4 (n = 32/43) 16.43 ± 8.6 (n = 43)
PI≥ 1 7.5 ± 7.2 (n = 43) 0.004 83.3 (n = 35/42) <0.001 16.3 ± 8.7 (n = 43) 0.73
PI < 1 0.1 ± 0.1 (n = 9) 0.30 (n = 3/10) 15.3 ± 1.5 (n = 9)
Table 4 Correlation of medical and periodontal findings in controls
Variable BOP (%) Mean ± SD P-value CAL≥ 5 mm % (n) P-value Number of teeth Mean ± SD P-value
Age≥ 45 years 2.35 ± 3.00 (n = 43) 0.84 33.3 (n = 14/42) 0.41 20.00 ± 8.84 (n = 43) 0.06
Age < 45 years 2.56 ± 2.01 (n = 9) 20.0 (n = 2/10) 25.89 ± 4.73 (n = 9)
HbA1c≥ 7 % - - - -
HbA1c < 7 % 2.50 ± 3.05 (n = 52) 38.46 (n = 20/52) 20.20 ± 8.99 (n = 52)
Current smokers 1.67 ± 1.97 (n = 6) 0.13 83.3 (n = 5/6) 0.016 18.67 ± 10.19 (n = 6) 0.48
Former and never smokers 2.48 ± 2.93 (n = 46) 32.6 (n = 15/46) 21.32 ± 8.38 (n = 46)
PI≥ 1 2.8 ± 2.6 (n = 48) 0.045 87.2 (n = 41/47) 0.008 21.4 ± 8.37 (n = 48) 0.84
PI < 1 0.1 ± 0.1 (n = 4) 40.0 (n = 2/5) 20.5 ± 11.8 (n = 4)
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(CAL ≥ 5 mm), but not with other periodontal parame-
ters [35]. In the present study, patients with T2DM and
good glycemic control (HbA1c < 7) showed significantly
better mean BOP indexes compared with patients who
had poor glycemic control (HbA1c ≥ 7). In contrast,
among patients with T2DM, comparison of periodontal
destruction (CAL ≥ 5 mm) and number of teeth did not
reach statistical significance between the metabolic
groups (good and poor glycemic control). Accordingly,
patients with well-controlled DM could have periodontal
disease, just as those with poorly controlled DM could
have a healthy periodontium [11].
Smoking is a known risk factor for periodontal dis-
ease [36]. In this study, the effect of current smoking
did not reach statistical significance when compared to
former and never smokers in the T2DM group. More-
over, statistical analysis failed to show significance be-
tween currently smoking controls and formerly and
never smoking controls, except in the percentage of
controls with severe periodontal destruction (CAL ≥
5 mm). This might suggest that smoking was not a
significant factor, which is consistent with recent litera-
ture [11]. Nevertheless, the findings in this study may
be explained by the small number of smokers in both
the T2DM and control groups (17.3 % and 11.5 %,
respectively).
Finally, the estimated mean BOP index and severe
periodontal destruction (CAL ≥ 5 mm) values were sig-
nificantly related to poor oral hygiene level (PI > 1) in
both the T2DM and control groups. This is consistent
with the literature [34]. In contrast, number of teeth was
not related to the PI in either the T2DM group or con-
trol group, which again may be attributable to the small
numbers with a PI < 1 in each group.
Genetic and microbiologic findings
As shown in Table 2, patients with T2DM hadworse peri-
odontal conditions when compared with healthy controls.
Therefore, intrinsic factors probably exerted an additional
influence, and in support of this, there is evidence in the
literature that periodontal health may be affected by poly-
morphisms in the interleukin 1 genotype [13, 37–39].
Indeed, it has been shown that specific interleukin 1 geno-
types could increase the risk of tooth loss by 2.7 times
[40]. In an attempt to explain the worse dental statuses of
patients with T2DM, we therefore compared periodontal
interleukin 1 genotypes between patients with and without
T2DM to discover whether patients with T2DM were
more likely to be positive for interleukin 1 genotypes.
However, statistical analysis failed to detect any significant
differences with respect to genetic groups A to D, suggest-
ing that the worse dental status of patients with T2DM
was not related to the interleukin 1 genotype. This is con-
sistent with the work of Lopez et al., who showed that
there were no statistically significant differences between
patients with T2DM and metabolically healthy controls
with respect to IL1A(−889), IL1B(+3954), and IL1RN ge-
notypes [37]. In our study, 32 % of the 104 participants
belonged to groups C and D, which corresponds to the
rate of 30–35 % reported for Europeans [13, 37, 39, 41].
Analysis of the selected subgingival microbiota resulted
in very similar results for both patients with T2DM and
controls across profiles 1 to 8. This is consistent with
existing research, which failed to show a significant differ-
ence in the subgingival plaque of participants with and
without diabetes [21]. In contrast, significantly more pa-
tients with T2DM have been shown to harbor P. gingivalis
when compared with nondiabetic controls [42]. However,
in that study, the recruited patients with T2DM had more
extensive periodontal disease than the control subjects,
and it is likely that the increased levels of P. gingivalis
were due to increased periodontitis rather than the pres-
ence of T2DM itself [12].
Limitations
This study has some limitations. First, patients were re-
cruited from an outpatient setting of a single university
hospital. Therefore, the patients might not be represen-
tative for the whole population. Second, only short-term
findings were recorded, and we cannot exclude com-
pletely that long-term evaluation may have produced dif-
ferent findings.
Conclusions
Within the limitations of this study, it may be stated that
patients with T2DM had worse oral hygiene and higher se-
verity of periodontitis. Moreover, there were no differences
with respect to the periodontal interleukin 1 genotype or
selected subgingival microbiota between patients with
Table 5 Genetic and microbiologic findings





Genetic group A 19 (36.5 %) 16 (30.8 %) 0.58
Genetic group B 16 (30.8 %) 19 (36.5 %) 0.58
Genetic group C 9 (17.3 %) 8 (15.4 %) 0.79
Genetic group D 8 (15.4 %) 9 (17.3 %) 0.79
Microbiological Profile 1 1 (1.9 %) 0 (0 %) 0.31
Microbiological Profile 2 26 (50 %) 19 (36.5 %) 0.17
Microbiological Profile 3 5 (9.6 %) 6 (11.5 %) 0.75
Microbiological Profile 4 2 (3.8 %) 0 (0 %) 0.15
Microbiological Profile 5 0 (0 %) 2 (3.8 %) 0.15
Microbiological Profile 6 0 (0 %) 0 (0 %) -
Microbiological Profile 7 3 (5.8 %) 3 (5.8 %) 1
Microbiological Profile 8 1 (1.9 %) 1 (1.9 %) 1
No Microbiological Profile 1–8 14 (26.9 %) 21 (40.4 %) 0.15
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T2DM and healthy controls. Therefore, we conclude
that the dental plaque level remains the major con-
tributory factor to progressive periodontitis in patients
with T2DM. In contrast, polymorphisms of the inter-
leukin 1 gene or differences in oral microbiota seem to
play a subordinate role.
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